Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients
Conditions
Multiple Myeloma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Shenzhen People's Hospital, Shenzhen, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University, Naning, Guangxi, China
Harbin Institute of Hematologic Oncology, Harbin, Heilongjiang, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology., Wuhan, Hubei, China
Jiangsu Provincial People's Hospital, Nanjing, Jiangsu, China
Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
Fudan University Affiliated Zhongshan Hospital, Shanghai, Shanghai Municipality, China
Xijing Hospital, Air Force Medical University, Xi’an, Shanxi, China
Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Study leads
Peng Liu
Principal Investigator
Fudan University